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Abstract
Conventional therapy for colorectal carcinoma using 5-fluorouracil (5-FU) has shown limited
antitumor action. The purpose of our study was to investigate synergistic antitumor effects of the
streptococcal preparation of OK-432 and 5-FU, and to elucidate the mechanisms of interaction
between the 2 agents in mice. Biochemical modulation of OK-432 and 5-FU were determined in
vivo against colon-26 carcinoma. The concentration of 5-FU and its metabolites, and the activity of
thymidylate synthase and thymidine kinase, respectively, were measured using cytosolic extracts
of the tumors. Combination treatment with OK-432 produced a significant increase in intratumor
5-FU and 5-FU in RNA (F-RNA) concentrations, increased the thymidylate synthetase inhibition
rate, and decreased thymidine kinase activity, as compared with the results observed in the control
mice. These additive antitumor effects are obtained by use of the 2 agents; the mechanism of
action is considered to be the suppression of both the de novo and the salvage pathway for DNA
synthesis, along with the suppression of RNA synthesis.
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